Skip to main content
. Author manuscript; available in PMC: 2015 Nov 13.
Published in final edited form as: Mol Diagn Ther. 2014 Aug;18(4):409–418. doi: 10.1007/s40291-014-0091-6

Table 1.

Summary of BRAF mutations in melanoma using initial and revised assays

Initial assay (n = 62) Revised assay (n = 131)
Positive, total 27 50
 p.V600E 25 (20)a 35
 p.V600K 0 (5)a 13
 p.V600R 0 1
 p.K601E 1 (1)a 0
 p.V600E K601IdelinsEI 1 (1)a 0
 p.V600_K601delinsE 0 1
a

Number in parentheses indicates mutations re-evaluated by the revised assay